IDEX Biometrics (IDEX) Q2 2025 earnings summary

Executive summary

• Operating expenses (excluding cost of materials and depreciation) reduced by 52% year-over-year for the first half of 2025, reflecting significant cost-cutting initiatives.

• Staff reduced to 30 FTEs by end of Q2 2025, down from 59 a year earlier, driving a 72% year-over-year reduction in compensation and benefits.

• Management changes include consolidation of CEO and CFO roles and appointment of a new COO.

• Launched the world’s first biometric payment card with EBL and Mastercard in Bangladesh, with positive market feedback and expected further orders.

Financial highlights

• Q2 2025 revenue was $0.1 million, down from $0.3 million in Q2 2024.

• Net loss for Q2 2025 was $2.1 million, a significant improvement from $6.7 million in Q2 2024.

• Gross margin on products sold in Q2 2025 was 29%.

• Cash balance at June 30, 2025, was $1.0 million, down from $2.1 million a year earlier.

• Net working capital at June 30, 2025, was $2.7 million, down from $6.6 million at June 30, 2024.

Outlook and guidance

• New Access and Pay products are on track for release in Q3 and Q4 2025, with positive initial customer feedback and several LOIs signed.

• Operational improvements target a quarterly OPEX run rate of $1.5–1.7 million by end of Q3 2025.

• Board assumes revenue generation in Q3 and Q4 2025, but acknowledges significant going concern risk.